Spearhead Capital Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-45,953	Closed	-$636K	–	198
2021 Q4	$636K	Buy	45,953 +399	+0.9%	+$5.52K	0.08%	82
2021 Q3	$655K	Sell	45,554 -132	-0.3%	-$1.9K	0.09%	74
2021 Q2	$722K	Buy	45,686 +3,616	+9%	+$57.1K	0.1%	74
2021 Q1	$428K	Buy	+42,070	New	+$428K	0.06%	92